Using virtual reality to help patients understand neurosurgery consent

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of virtual reality (VR) in enhancing patient comprehension during the informed consent process for neurosurgery. By utilizing VR technology, the study aims to improve the patient-doctor relationship and reduce anxiety associated with complex surgical procedures. The trial will also assess the cost-benefit ratio and feasibility of implementing VR in routine clinical settings, focusing on patients undergoing surgical clipping for intracranial aneurysms, resection of vascular malformations, or craniotomy for tumor removal.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients between the age of 18 and 75
* Surgical clipping for intracranial aneurysm, resection of vascular malformations
* Craniotomy and Resection of intracranial tumors that can be segmented for VR

Exclusion Criteria:

* Visual or auditory impairment with no sufficient aid
* Patient that had VR informed consent for surgery before
* Psychiatric illness, cognitive impairment

Where it's running

• University Hospital Basel
  Basel, Switzerland Recruiting

Study contacts

• Principal investigator: Emilia Westarp, Dr. — University Hospital, Basel, Switzerland
• Study coordinator: Raphael Guzman, Prof. Dr.
• Email: raphael.guzman@usb.ch
• Phone: +41 61 32 87522

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Predicting bowel leaks after colorectal surgery with a computer model and surgeon input

  This study tests a computer model that predicts anastomotic leaks after colorectal surgery, and sees if adding surgeons’ intuition improves the predictions.

  Recruiting at 2 sites University Hospital, Basel, Switzerland · Liestal, Basel-Landschaft and 1 other locations · NCT07888478

• Active surveillance after immunotherapy for MMR-deficient colorectal and GI cancers

  This study looks at whether some patients with non-metastatic, MMR-deficient or MSI-H colorectal cancers can skip surgery after a strong response to immunotherapy.

  Recruiting at 3 sites University Hospital, Basel, Switzerland · Basel and 2 other locations · NCT07829081

• PCI Registry at University Hospital Basel for Complex Coronary Procedures

  This registry collects real-world data from adults undergoing percutaneous coronary interventions at University Hospital Basel to see how different treatments like drug-eluting stents, drug-coated balloons, and bioresorbable scaffolds perform in diverse patients.

  Recruiting University Hospital, Basel, Switzerland · Basel, Canton of Basel-City · NCT07814157

• Severe Complications During VT/PVC Ablation

  This study looks at real-world cases to see what severe complications occur during VT or PVC ablations and how patients are managed afterward.

  Recruiting at 25 sites University Hospital, Basel, Switzerland · Chicago, Illinois and 24 other locations · NCT07777744

• Visioning III: Five-year follow-up for MRI-based prostate cancer screening

  This study tests a repeat MRI-based screening approach for men who previously had no cancer signs, to see if a negative bpMRI reliably predicts no significant cancer for at least five years.

  Recruiting University Hospital, Basel, Switzerland · Basel, Canton of Basel-City · NCT07762911

• Oxytocin in postmenopausal and premenopausal women

  Researchers will test whether cumulative endogenous neurophysin I, a surrogate for oxytocin, differs over a month between premenopausal and postmenopausal women.

  Recruiting University Hospital, Basel, Switzerland · Basel, Canton of Basel-City · NCT07742124

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.